Plain-English translation of NCT07187713 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing , a liquid medication you place under your tongue four times daily, to see if it can help protect your kidneys and reduce the amount of protein in your urine. The medication contains natural peptides and amino acids designed to reduce scarring in the kidneys and improve blood flow. The study will follow 300 people with different types of kidney damage over 12 weeks to measure how well this treatment works.
Kidney disease from diabetes, high blood pressure, and autoimmune conditions often leads to progressive damage that current treatments cannot always stop. Researchers are testing whether this medication can slow or reduce that damage by working through different biological pathways than existing kidney disease treatments.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic at baseline and then at weeks 4, 8, 12, and 16 for check-ups and blood and urine tests. At home, you will place 1 milliliter of the liquid medication under your tongue four times daily for 12 weeks. The study lasts about 4 months total, including a 4-week safety check-in after you stop taking the medication.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Egypt